Skip to main content
Top
Published in: BMC Urology 1/2016

Open Access 01-12-2016 | Research article

The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population

Authors: H. Henry Lai, Baixin Shen, Amar Rawal, Joel Vetter

Published in: BMC Urology | Issue 1/2016

Login to get access

Abstract

Background

To investigate the relationship between depression and overactive bladder (OAB)/urinary incontinence symptoms among the clinical OAB population.

Methods

Patients who were diagnosed with overactive bladder (OAB) and age-matched control subjects without OAB were enrolled. Depression symptoms were assessed using the Hospital Anxiety and Depression Scale (HADS-D). OAB/incontinence symptoms were assessed using the validated questionnaires: ICIQ-UI, ICIQ-OAB, UDI-6, IIQ-7, and OAB-q.

Results

27.5 % of OAB patients in our study had depression (HADS ≥8), and 12 % of OAB patients had moderate to severe depression (HADS-D ≥11). OAB patients reported significantly higher HADS-D depression scores compared to age-matched controls (5.3 ± 3.9 versus 2.8 ± 3.9, p = 0.004). OAB patients with depression reported more severe incontinence symptoms (ICIQ-UI), greater bother and more impact on quality of life (UDI-6, IIQ-7) compared to OAB patients without depression (p = 0.001, 0.01, <0.001, respectively). However there were no differences in ICIQ-OAB and OAB-q. Among OAB patients, there were positive correlations between the severity of depression symptoms and OAB/incontinence symptoms (p-values <0.001 to 0.035).

Conclusions

27.5 % of OAB patients have depression. OAB patients with depression reported more severe urinary incontinence symptoms, greater bother and more impact on quality of life compared to those without depression. Future studies are needed to further examine the mechanistic links between depression and OAB/urinary incontinence.
Appendix
Available only for authorised users
Literature
1.
go back to reference Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327.PubMed Stewart WF, Van Rooyen JB, Cundiff GW, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003;20:327.PubMed
2.
go back to reference Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167.CrossRefPubMed Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21:167.CrossRefPubMed
3.
go back to reference Vrijens D, Drossaerts J, van Koeveringe G, et al. Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res. 2015;78:95.CrossRefPubMed Vrijens D, Drossaerts J, van Koeveringe G, et al. Affective symptoms and the overactive bladder - a systematic review. J Psychosom Res. 2015;78:95.CrossRefPubMed
4.
go back to reference Melville JL, Walker E, Katon W, et al. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol. 2002;187:80.CrossRefPubMed Melville JL, Walker E, Katon W, et al. Prevalence of comorbid psychiatric illness and its impact on symptom perception, quality of life, and functional status in women with urinary incontinence. Am J Obstet Gynecol. 2002;187:80.CrossRefPubMed
5.
go back to reference Sung VW, West DS, Hernandez AL, et al. Association between urinary incontinence and depressive symptoms in overweight and obese women. Am J Obstet Gynecol. 2009;200:557 e1.CrossRef Sung VW, West DS, Hernandez AL, et al. Association between urinary incontinence and depressive symptoms in overweight and obese women. Am J Obstet Gynecol. 2009;200:557 e1.CrossRef
6.
go back to reference Chiara G, Piccioni V, Perino M, et al. Psychological investigation in female patients suffering from urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9:73.CrossRefPubMed Chiara G, Piccioni V, Perino M, et al. Psychological investigation in female patients suffering from urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 1998;9:73.CrossRefPubMed
7.
go back to reference Stach-Lempinen B, Hakala AL, Laippala P, et al. Severe depression determines quality of life in urinary incontinent women. Neurourol Urodyn. 2003;22:563.CrossRefPubMed Stach-Lempinen B, Hakala AL, Laippala P, et al. Severe depression determines quality of life in urinary incontinent women. Neurourol Urodyn. 2003;22:563.CrossRefPubMed
8.
9.
go back to reference Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455.CrossRefPubMed Gormley EA, Lightner DJ, Burgio KL, et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol. 2012;188:2455.CrossRefPubMed
10.
go back to reference Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361.CrossRefPubMed Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67:361.CrossRefPubMed
11.
go back to reference Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res. 1997;42:17.CrossRefPubMed Herrmann C. International experiences with the Hospital Anxiety and Depression Scale--a review of validation data and clinical results. J Psychosom Res. 1997;42:17.CrossRefPubMed
12.
go back to reference Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23:322.CrossRefPubMed Avery K, Donovan J, Peters TJ, et al. ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence. Neurourol Urodyn. 2004;23:322.CrossRefPubMed
13.
go back to reference Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805.CrossRefPubMed Jackson S, Donovan J, Brookes S, et al. The Bristol Female Lower Urinary Tract Symptoms questionnaire: development and psychometric testing. Br J Urol. 1996;77:805.CrossRefPubMed
14.
go back to reference Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563.CrossRefPubMed Coyne K, Revicki D, Hunt T, et al. Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q. Qual Life Res. 2002;11:563.CrossRefPubMed
15.
go back to reference Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14:131.CrossRefPubMed Uebersax JS, Wyman JF, Shumaker SA, et al. Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program for Women Research Group. Neurourol Urodyn. 1995;14:131.CrossRefPubMed
16.
go back to reference de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology. 2002;59:30.CrossRefPubMed de Groat WC. Influence of central serotonergic mechanisms on lower urinary tract function. Urology. 2002;59:30.CrossRefPubMed
17.
go back to reference Steers WD, Herschorn S, Kreder KJ, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007;100:337.CrossRefPubMed Steers WD, Herschorn S, Kreder KJ, et al. Duloxetine compared with placebo for treating women with symptoms of overactive bladder. BJU Int. 2007;100:337.CrossRefPubMed
18.
go back to reference Perry S, McGrother CW, Turner K, et al. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11:463.CrossRefPubMed Perry S, McGrother CW, Turner K, et al. An investigation of the relationship between anxiety and depression and urge incontinence in women: development of a psychological model. Br J Health Psychol. 2006;11:463.CrossRefPubMed
19.
go back to reference Nuotio M, Luukkaala T, Tammela TL, et al. Six-year follow-up and predictors of urgency-associated urinary incontinence and bowel symptoms among the oldest old: a population-based study. Arch Gerontol Geriatr. 2009;49:e85.CrossRefPubMed Nuotio M, Luukkaala T, Tammela TL, et al. Six-year follow-up and predictors of urgency-associated urinary incontinence and bowel symptoms among the oldest old: a population-based study. Arch Gerontol Geriatr. 2009;49:e85.CrossRefPubMed
20.
go back to reference Hirayama A, Torimoto K, Mastusita C, et al. Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study. Urology. 2012;80:71.CrossRefPubMed Hirayama A, Torimoto K, Mastusita C, et al. Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study. Urology. 2012;80:71.CrossRefPubMed
21.
go back to reference Esin E, Ergen A, Cankurtaran M, et al. Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder. Aging Ment Health. 2015;19:217.CrossRefPubMed Esin E, Ergen A, Cankurtaran M, et al. Influence of antimuscarinic therapy on cognitive functions and quality of life in geriatric patients treated for overactive bladder. Aging Ment Health. 2015;19:217.CrossRefPubMed
22.
go back to reference Levin PJ, Siddiqui NY, Wu JM, et al. Psychosocial factors related to the use of InterStim(R) for the treatment of refractory overactive bladder. Female Pelvic Med Reconstr Surg. 2014;20:272.CrossRefPubMed Levin PJ, Siddiqui NY, Wu JM, et al. Psychosocial factors related to the use of InterStim(R) for the treatment of refractory overactive bladder. Female Pelvic Med Reconstr Surg. 2014;20:272.CrossRefPubMed
23.
go back to reference Game X, Khan S, Panicker JN, et al. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity. BJU Int. 2011;107:1786.CrossRefPubMed Game X, Khan S, Panicker JN, et al. Comparison of the impact on health-related quality of life of repeated detrusor injections of botulinum toxin in patients with idiopathic or neurogenic detrusor overactivity. BJU Int. 2011;107:1786.CrossRefPubMed
Metadata
Title
The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population
Authors
H. Henry Lai
Baixin Shen
Amar Rawal
Joel Vetter
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Urology / Issue 1/2016
Electronic ISSN: 1471-2490
DOI
https://doi.org/10.1186/s12894-016-0179-x

Other articles of this Issue 1/2016

BMC Urology 1/2016 Go to the issue